Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic
  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

CureVac vaccine struggles in trial, particularly against variants

CureVac NV (Nasdaq: CVAC), headquartered in Germany with a U.S. office in Boston, announced on Wednesday that its Covid-19 vaccine candidate was just 47% effective against "any severity" of the disease in an interim analysis, failing to meet the criteria the company had initially laid out.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.